The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
DNA targeting specificity of RNA-guided Cas9 nucleases
Open accessAbstract
The Streptococcus pyogenes Cas9 (SpCas9) nuclease can be efficiently targeted to genomic loci by means of single-guide RNAs (sgRNAs) to enable genome editing. Here, we characterize SpCas9 targeting specificity in human cells to inform the selection of target sites and avoid off-target effects. Our study evaluates >700 guide RNA variants and SpCas9-induced indel mutation levels at >100 predicted genomic off-target loci in 293T and 293FT cells. We find that SpCas9 tolerates mismatches between guide RNA and target DNA at different positions in a sequence-dependent manner, sensitive to the number, position and distribution of mismatches. We also show that SpCas9-mediated cleavage is unaffected by DNA methylation and that the dosage of SpCas9 and sgRNA can be titrated to minimize off-target modification. To facilitate mammalian genome engineering applications, we provide a web-based software tool to guide the selection and validation of target sequences as well as off-target analyses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, off-target cleavages of the Cas9 nucleases that cause oncogenic mutations in the genome have been reported extensively [123,124].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [123]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The off-target sites are often sgRNA-dependent, since Cas9 is known to tolerate up to 3 mismatches between sgRNA and genomic DNA (Fu et al., 2013; Hsu et al., 2013; Wang et al., 2016a).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Hsu et al., 2013
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although CRISPR/Cas systems exhibit tremendous potential in translational medicine, off-target effects remain a major challenge (Fu et al., 2013; Hsu et al., 2013; Pacesa et al., 2022).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Hsu et al., 2013
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and it maintains cleaving activity even with 3-5 mismatches at the PAM-distal end of the gRNA molecule [59,81,102].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [102]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The algorithm of MIT weights the position effect of the mismatches in the sgRNA to generate a score to evaluate off-target effects (Hsu et al., 2013; Haeussler et al., 2016).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Hsu et al., 2013
The cited source says what the claim attributes to it.
In the citing paper
“The PAM sequence adjacent to the target sequence greatly affects the editing efficiency and editing range of Cas9.”
From Machine learning-based prediction models to guide the selection of Cas9 variants for efficient gene editing (2024) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“Cas9 is guided by a 20 nt fraction of the gRNA”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [102]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Recombinant expression and purification of EvoCas9–1 paired with chemically synthesized Evo-generated single guide RNA (sgRNA) exhibited comparable in vitro cleavage activity to SpCas9 paired with the canonical SpCas9 sgRNA”
From Sequence modeling and design from molecular to genome scale with Evo (2024) · cites this paper as [63]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“When two sgRNAs are designed to simultaneously cut the two opposite strands of DNA within a small distance, DSBs can be created with markedly lower off-target effects (Hsu et al., 2013; Frock et al., 2015).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Hsu et al., 2013
Experimental — accuracy not yet measuredIn the citing paper
“By bioinformatic screening and efficiency/off-target prediction (14, 15), we identified four gRNA targets (protospacers; LTRs A-D) that avoid conserved transcription factor binding sites, minimizing the likelihood of altering host gene expression”
From RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection (2014) · cites this paper as [14]
In the citing paper
“as mentioned in several recent publications, Cas9 tolerates mismatches between the guide RNA and target DNA in a sequence-dependent manner and potentially tolerates up to five target mismatches in human cells [12], [24], [25], [26], [27], thereby promoting undesired off-target mutations.”
From High-efficiency targeted editing of large viral genomes by RNA-guided nucleases (2014) · cites this paper as [25]
In the citing paper
“Because the sequence specificity of Streptococcus pyogenes Cas9 tolerates 4 mismatches between the gRNA and complementary sequence”
From High-efficiency targeted editing of large viral genomes by RNA-guided nucleases (2014) · cites this paper as [25]
In the citing paper
“non-specific cleavage may occur in the cellular genome [12], [24], [25], [26], [27].”
From High-efficiency targeted editing of large viral genomes by RNA-guided nucleases (2014) · cites this paper as [25]
In the citing paper
“However, it has been recently shown that CRISPR/Cas9 system can be highly active even when mismatches occur between gRNA and their DNA targets”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [91]
In the citing paper
“multiple mismatches between the guide RNA and its complementary target DNA sequence can be tolerated depending on the quantity, position, and base identity of mismatches [87,90,91,93], all of which contribute to potential off-target activity.”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [91]
In the citing paper
“and off-target mutations occur at endogenous loci in human cells with high frequency [90,91,92].”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [91]
In the citing paper
“Collectively, these studies indicate that although each base within the 20 nt guide sequence contributes to overall specificity”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Self-citationRNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Self-citationEfficient genome editing in zebrafish using a CRISPR-Cas system
Hwang, W. Y., Fu, Y., Reyon, D., Maeder, M. L., Tsai, S. Q., Sander, J. D., Peterson, R. T., Yeh, J.-R. J., & Joung, J. K. (2013) · Nature Biotechnology · doi:10.1038/nbt.2501 · Cited by 2,937
CRISPR RNA Maturation by Trans-Encoded Small RNA and Host Factor RNase III
Deltcheva, E., Chylinski, K., Sharma, C. M., Gonzales, K., Chao, Y., Pirzada, Z. A., Eckert, M. R., Vogel, J., & Charpentier, E. (2011) · Nature · doi:10.1038/nature09886 · Cited by 2,563
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2508 · Cited by 2,429
Self-citationA TALE nuclease architecture for efficient genome editing
Miller, J. C., Tan, S., Qiao, G., Barlow, K. A., Wang, J., Xia, D. F., Meng, X., Paschon, D. E., Leung, E., Hinkley, S. J., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1755 · Cited by 2,098
RNA-programmed genome editing in human cells
Jinek, M., East, A., Cheng, A., Lin, S., Ma, E., & Doudna, J. (2013) · eLife · doi:10.7554/elife.00471 · Cited by 2,098
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 1,041
High-Throughput Genome Editing and Phenotyping Facilitated by High Resolution Melting Curve Analysis
Thomas, H. R., Percival, S. M., Yoder, B. K., & Parant, J. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114632 · Cited by 137
Nielsen, A. A. K., Segall-Shapiro, T. H., & Voigt, C. A. (2013) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2013.10.003 · Cited by 139
KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function
Gala, K. P., Li, Q., Sinha, A., Razavi, P., Dorso, M. A., Sánchez-Vega, F., Chung, Y. R., Hendrickson, R. C., Hsieh, J. J.-D., Berger, M. F., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0273-5 · Cited by 137
Generation of improved humanized mouse models for human infectious diseases
Brehm, M. A., Wiles, M. V., Greiner, D. L., & Shultz, L. D. (2014) · Journal of Immunological Methods · doi:10.1016/j.jim.2014.02.011 · Cited by 137
Buffet, A., Morin, A., Castro‐Vega, L. J., Habarou, F., Lussey‐Lepoutre, C., Letouzé, É., Lefèbvre, H., Guilhem, I., Haissaguerre, M., Raingeard, I., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2463 · Cited by 137
Fan, Y., & Lin, X. (2018) · Genetics · doi:10.1534/genetics.117.300656 · Cited by 136
Efficient homologous recombination-mediated genome engineering in zebrafish using TALE nucleases
Shin, J., Chen, J., & Solnica‐Krezel, L. (2014) · Development · doi:10.1242/dev.108019 · Cited by 135
Sex steroids regulate skin pigmentation through nonclassical membrane-bound receptors
Natale, C. A., Duperret, E. K., Zhang, J., Sadeghi, R. S., Dahal, A., O'Brien, K. T., Cookson, R., Winkler, J. D., & Ridky, T. W. (2016) · eLife · doi:10.7554/elife.15104 · Cited by 138
Broad Targeting Specificity during Bacterial Type III CRISPR-Cas Immunity Constrains Viral Escape
Pyenson, N. C., Gayvert, K. M., Varble, A., Elemento, O., & Marraffini, L. A. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.07.016 · Cited by 135
Self-citationCRISPR-Cas in Streptococcus pyogenes
Rhun, A. L., Escalera-Maurer, A., Bratovič, M., & Charpentier, E. (2019) · RNA Biology · doi:10.1080/15476286.2019.1582974 · Cited by 143
Mitigating off-target effects in CRISPR/Cas9-mediated in vivo gene editing
Han, H. A., Pang, J. K. S., & Soh, B.-S. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01893-z · Cited by 134
“However, Cas9 is able to bind to the target with a tolerance of up to 10 mismatches between the target sequence and the sgRNA while DNA cleavage can be detected at a small minority of loci with a mismatch of 3–5 base pairs [18, 20, 46].”
BackgroundMethodGeneration and validation of homozygous fluorescent knock-in cells using CRISPR-Cas9 genome editing
Koch, B., Nijmeijer, B., Kueblbeck, M., Cai, Y., Walther, N., & Ellenberg, J. (2018) · Nature Protocols · doi:10.1038/nprot.2018.042 · Cited by 134
Crystal structure of the human lysosomal mTORC1 scaffold complex and its impact on signaling
de Araujo, M. E. G., Naschberger, A., Fürnrohr, B. G., Stasyk, T., Dunzendorfer-Matt, T., Lechner, S., Welti, S., Kremser, L., Shivalingaiah, G., Offterdinger, M., et al. (2017) · Science · doi:10.1126/science.aao1583 · Cited by 134
Surrogate reporter-based enrichment of cells containing RNA-guided Cas9 nuclease-induced mutations
Ramakrishna, S., Cho, S. W., Kim, S., Song, M., Gopalappa, R., Kim, J., & Kim, S. (2014) · Nature Communications · doi:10.1038/ncomms4378 · Cited by 134
Yang, L., Grishin, D., Wang, G., Aach, J., Zhang, C., Chari, R., Homsy, J. G., Cai, X., Zhao, Y., Fan, J., et al. (2014) · Nature Communications · doi:10.1038/ncomms6507 · Cited by 133
TPC2 controls pigmentation by regulating melanosome pH and size
Ambrosio, A. L., Boyle, J. A., Aradi, A., Christian, K. A., & Pietro, S. M. D. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600108113 · Cited by 141
Pankowicz, F. P., Barzi, M., Legras, X. D., Hubert, L., Tian, M., Tomolonis, J., Ravishankar, M., Sun, Q., Yang, D., Borowiak, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms12642 · Cited by 136
Zhang, D., Zhang, H., Li, T., Chen, K., Qiu, J., & Gao, C. (2017) · Genome biology · doi:10.1186/s13059-017-1325-9 · Cited by 133
Xu, X., Li, C., Gao, X., Xia, K., Guo, H., Li, Y., Hao, Z., Zhang, L., Gao, D., Xu, C., et al. (2017) · Cell Research · doi:10.1038/cr.2017.132 · Cited by 132
Self-citationMancini, A., Xavier‐Magalhães, A., Woods, W. S., Nguyen, K.-T., Amen, A. M., Hayes, J. L., Fellmann, C., Gapinske, M., McKinney, A., Hong, C., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.08.003 · Cited by 136
Vaidyanathan, S., Salahudeen, A. A., Sellers, Z. M., Bravo, D. T., Choi, S. S., Batish, A., Le, W., Baik, R., Sean de la, O., Kaushik, M. P., et al. (2019) · Cell stem cell · doi:10.1016/j.stem.2019.11.002 · Cited by 141
Self-citationHousden, B. E., Valvezan, A. J., Kelley, C., Sopko, R., Hu, Y., Roesel, C. L., Lin, S., Buckner, M., Tao, R., Yilmazel, B., et al. (2015) · Science Signaling · doi:10.1126/scisignal.aab3729 · Cited by 134
Highly specific targeted mutagenesis in plants using Staphylococcus aureus Cas9
Kaya, H., Mikami, M., Endo, A., Endo, M., & Toki, S. (2016) · Scientific Reports · doi:10.1038/srep26871 · Cited by 135
Gesicle-Mediated Delivery of CRISPR/Cas9 Ribonucleoprotein Complex for Inactivating the HIV Provirus
Campbell, L. A., Coke, L. M., Richie, C. T., Fortuno, L. V., Park, A. Y., & Harvey, B. K. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.10.002 · Cited by 140
Activating PTEN Tumor Suppressor Expression with the CRISPR/dCas9 System
Moses, C., Nugent, F., Waryah, C. B., García‐Bloj, B., Harvey, A. R., & Blancafort, P. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.12.003 · Cited by 133
Genetic Biocontrol for Invasive Species
Teem, J. L., Alphey, L., Descamps, S., Edgington, M. P., Edwards, O. R., Gemmell, N. J., Harvey‐Samuel, T., Melnick, R. L., Oh, K. P., Piaggio, A. J., et al. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00452 · Cited by 134
High-performance CRISPR-Cas12a genome editing for combinatorial genetic screening
Gier, R. A., Budinich, K. A., Evitt, N. H., Cao, Z., Freilich, E., Chen, Q., Qi, J., Lan, Y., Kohli, R. M., & Shi, J. (2020) · Nature Communications · doi:10.1038/s41467-020-17209-1 · Cited by 135
Massively parallel kinetic profiling of natural and engineered CRISPR nucleases
Jones, S. K., Hawkins, J. A., Johnson, N. V., Jung, C., Hu, K., Rybarski, J. R., Chen, J. S., Doudna, J. A., Press, W. H., & Finkelstein, I. J. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0646-5 · Cited by 131
Repurposing CRISPR/Cas9 for in situ functional assaysPreprint
Malina, A., Mills, J. R., Cencic, R., Yan, Y., Fraser, J., Nederveen-Schippers, L. M., Paquet, M., Dostie, J., & Pelletier, J. (2013) · Genes & Development · doi:10.1101/gad.227132.113 · Cited by 132
Genome editing at the crossroads of delivery, specificity, and fidelity
Maggio, I., & Gonçalves, M. A. F. V. (2015) · Trends in biotechnology · doi:10.1016/j.tibtech.2015.02.011 · Cited by 135
An online bioinformatics tool predicts zinc finger and TALE nuclease off-target cleavage
Fine, E. J., Cradick, T. J., Zhao, C. L., Lin, Y., & Bao, G. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1326 · Cited by 139
Self-citationPromoting Cas9 degradation reduces mosaic mutations in non-human primate embryos
Tu, Z., Yang, W., Yan, S., Yin, A., Gao, J., Liu, X., Zheng, Y., Zheng, J., Li, Z., Yang, S., et al. (2017) · Scientific Reports · doi:10.1038/srep42081 · Cited by 135
Halim, D., Wilson, M. P., Oliver, D., Brosens, E., Verheij, J. B. G. M., Yu, H., Nanda, V., Lyu, Q., Doukas, M., Stoop, H., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620507114 · Cited by 132
Weninger, A., Fischer, J. E., Raschmanová, H., Kniely, C., Vogl, T., & Glieder, A. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26474 · Cited by 133
Genotyping with CRISPR-Cas-derived RNA-guided endonucleases
Kim, J. M., Kim, D., Kim, S., & Kim, J. (2014) · Nature Communications · doi:10.1038/ncomms4157 · Cited by 129
CRISPR/Cas9 mediated genome engineering in Drosophila
Bassett, A. R., & Liu, J. (2014) · Methods · doi:10.1016/j.ymeth.2014.02.019 · Cited by 131
One-step generation of triple knockout CHO cell lines using CRISPR/Cas9 and fluorescent enrichment
Grav, L. M., Lee, J. S., Gerling, S., Kallehauge, T. B., Hansen, A. H., Kol, S., Lee, G. M., Pedersen, L. E., & Kildegaard, H. F. (2015) · Biotechnology Journal · doi:10.1002/biot.201500027 · Cited by 131
Armstrong, G. A. B., Liao, M., You, Z., Lissouba, A., Chen, B. E., & Drapeau, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150188 · Cited by 138
Removal of Integrated Hepatitis B Virus DNA Using CRISPR-Cas9
Li, H., Sheng, C., Wang, S., Yang, L., Liang, Y., Huang, Y., Liu, H., Li, P., Yang, C., Yang, X., et al. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00091 · Cited by 131
A Revolution toward Gene-Editing Technology and Its Application to Crop Improvement
Ahmar, S., Saeed, S., Khan, M. H. U., Khan, S. U., Mora-Poblete, F., Kamran, M. A., Faheem, A., Maqsood, A., Rauf, M., Saleem, S., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165665 · Cited by 136
Chu, V. T., Graf, R., Wirtz, T., Weber, T., Favret, J., Li, X., Petsch, K., Tran, N. T., Sieweke, M. H., Berek, C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613884113 · Cited by 129
Crossing enhanced and high fidelity SpCas9 nucleases to optimize specificity and cleavage
Kulcsár, P. I., Tálas, A., Huszár, K., Ligeti, Z., Tóth, E., Weinhardt, N., Fodor, E., & Welker, E. (2017) · Genome biology · doi:10.1186/s13059-017-1318-8 · Cited by 134
Resistance to coronavirus infection in amino peptidase N-deficient pigs
Whitworth, K. M., Rowland, R. R. R., Petrovan, V., Sheahan, M. A., Cino-Ozuna, A. G., Fāng, Y., Hesse, R. A., Mileham, A. J., Samuel, M., Wells, K. D., et al. (2018) · Transgenic Research · doi:10.1007/s11248-018-0100-3 · Cited by 130
Genome editing: A perspective on the application of CRISPR/Cas9 to study human diseases (Review)
Rodríguez-Rodríguez, D. R., Ram�rez‐Sol�s, R., Garza‐Elizondo, M. A., Garza‐Rodr�guez, M., & Barrera-Saldaña, H. A. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4112 · Cited by 145
RNA Strand Displacement Responsive CRISPR/Cas9 System for mRNA Sensing
Li, Y., Teng, X., Zhang, K., Deng, R., & Li, J. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.8b05238 · Cited by 128
Self-citationRecent Advances in Genome Editing Using CRISPR/Cas9
Ding, Y., Li, H., Chen, L., & Xie, K. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.00703 · Cited by 144
Implications of human genetic variation in CRISPR-based therapeutic genome editing
Scott, D. A., & Zhang, F. (2017) · Nature Medicine · doi:10.1038/nm.4377 · Cited by 129
Self-citationVersatile detection with CRISPR/Cas system from applications to challenges
Wu, H., Chen, X., Zhang, M., Wang, X., Chen, Y., Qian, C., Wu, J. F., & Xu, J. (2020) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2020.116150 · Cited by 130
Computational Tools and Resources for CRISPR/Cas Genome Editing
Li, C., Chu, W., Gill, R. A., Sang, S., Shi, Y., Hu, X., Yang, Y., Zaman, Q. U., & Zhang, B. (2022) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2022.02.006 · Cited by 134
“Additionally, nucleotide positions are important for target specificity, and atypical PAM could be recognized by CRISPR/Cas9 as well [33,37].”
BackgroundInfluentialLoureiro, A., & da Silva, G. J. (2019) · Antibiotics · doi:10.3390/antibiotics8010018 · Cited by 129
Pamies, D. (2018) · ALTEX · doi:10.14573/altex.1710081 · Cited by 127
Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells
Okada, M., Kanamori, M., Someya, K., Nakatsukasa, H., & Yoshimura, A. (2017) · Epigenetics & Chromatin · doi:10.1186/s13072-017-0129-1 · Cited by 129
Genome-wide specificity of prime editors in plants
Jin, S., Lin, Q., Luo, Y., Zhu, Z., Liu, G., Li, Y., Chen, K., Qiu, J., & Gao, C. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00891-x · Cited by 131
Self-citationClaussnitzer, M., Dankel, S. N., Klocke, B., Grallert, H., Glunk, V., Berulava, T., Lee, H., Oskolkov, N., Fadista, J., Ehlers, K., et al. (2014) · Cell · doi:10.1016/j.cell.2013.10.058 · Cited by 133
Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells
Mungenast, A. E., Siegert, S., & Tsai, L. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.11.010 · Cited by 136
In Silico Meets In Vivo : Towards Computational CRISPR-Based sgRNA Design
Chuai, G., Wang, Q., & Liu, Q. (2016) · Trends in biotechnology · doi:10.1016/j.tibtech.2016.06.008 · Cited by 134
Giannelli, S. G., Luoni, M., Castoldi, V., Massimino, L., Cabassi, T., Angeloni, D., Demontis, G. C., Leocani, L., Andreazzoli, M., & Broccoli, V. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx438 · Cited by 133
CRISPR/Cas9 gene-editing: Research technologies, clinical applications and ethical considerations
Memi, F., Ntokou, A., & Papangeli, I. (2018) · Seminars in Perinatology · doi:10.1053/j.semperi.2018.09.003 · Cited by 134
Highly efficient genome editing for single-base substitutions using optimized ssODNs with Cas9-RNPs
Okamoto, S., Amaishi, Y., Maki, I., Enoki, T., & Mineno, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-41121-4 · Cited by 135
Li, M., Xie, H., Liu, Y., Xia, C., Cun, X., Long, Y., Chen, X., Deng, M., Guo, R., Zhang, Z., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.05.019 · Cited by 128
Polstein, L. R., Pérez‐Piñera, P., Koçak, D. D., Vockley, C. M., Bledsoe, P. J., Song, L., Safi, A., Crawford, G. E., Reddy, T. E., & Gersbach, C. A. (2015) · Genome Research · doi:10.1101/gr.179044.114 · Cited by 132
Targeted mutagenesis in a human-parasitic nematode
Gang, S. S., Castelletto, M. L., Bryant, A. S., Yang, E. C., Mancuso, N., Lopez, J. B., Pellegrini, M. A., & Hallem, E. A. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006675 · Cited by 123
Martín‐Pizarro, C., Triviño, J. C., & Posé, D. (2018) · Journal of Experimental Botany · doi:10.1093/jxb/ery400 · Cited by 126
The effect of LRRK2 loss-of-function variants in humans
Whiffin, N., Armean, I. M., Kleinman, A., Marshall, J. L., Minikel, E. V., Goodrich, J. K., Quaife, N. M., Cole, J. B., Wang, Q. S., Karczewski, K. J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0893-5 · Cited by 126
Multiplex genome-editing technologies for revolutionizing plant biology and crop improvement
Abdelrahman, M., Wei, Z., Rohila, J. S., & Zhao, K. (2021) · Frontiers in Plant Science · doi:10.3389/fpls.2021.721203 · Cited by 125
Drosophila melanogaster Oogenesis: An Overview
McLaughlin, J. M., & Bratu, D. P. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2851-4_1 · Cited by 125
Zhong, C., Yin, Q., Xie, Z., Bai, M., Dong, R., Tang, W., Xing, Y., Zhang, H., Yang, S., Chen, L., et al. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.06.005 · Cited by 118
NmeCas9 is an intrinsically high-fidelity genome-editing platform
Amrani, N., Gao, X. D., Liu, P., Edraki, A., Mir, A., Ibraheim, R., Gupta, A., Sasaki, K. E., Wu, T., Donohoue, P. D., et al. (2018) · Genome biology · doi:10.1186/s13059-018-1591-1 · Cited by 128
Cut Site Selection by the Two Nuclease Domains of the Cas9 RNA-guided Endonuclease
Chen, H., Choi, J., & Bailey, S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.539726 · Cited by 131
Genome editing with CRISPR/Cas9 in postnatal mice corrects PRKAG2 cardiac syndrome
Xie, C., Zhang, Y., Song, L., Luo, J., Qi, W., Hu, J., Lu, D., Yang, Z. H., Zhang, J., Xiao, J., et al. (2016) · Cell Research · doi:10.1038/cr.2016.101 · Cited by 132
Wang, G., Zhao, N., Berkhout, B., & Das, A. T. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.11.057 · Cited by 124
Targeting genomic rearrangements in tumor cells through Cas9-mediated insertion of a suicide gene
Chen, Z., Yu, Y. P., Zuo, Z., Nelson, J. B., Michalopoulos, G. K., Monga, S. P., Liu, S., Tseng, G. C., & Luo, J. (2017) · Nature Biotechnology · doi:10.1038/nbt.3843 · Cited by 125
Characterization of noncoding regulatory DNA in the human genome
Elkon, R., & Agami, R. (2017) · Nature Biotechnology · doi:10.1038/nbt.3863 · Cited by 132
The Current State and Future of CRISPR-Cas9 gRNA Design Tools
Wilson, L. O. W., O’Brien, A. R., & Bauer, D. C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00749 · Cited by 124
Human genetic diversity alters off-target outcomes of therapeutic gene editing
Cancellieri, S., Zeng, J., Lin, L. Y., Tognon, M., Nguyen, M. A., Lin, J., Bombieri, N., Maitland, S. A., Ciuculescu, M.-F., Katta, V., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01257-y · Cited by 125
Protospacer adjacent motif (PAM)-distal sequences engage CRISPR Cas9 DNA target cleavage
Cencic, R., Miura, H., Malina, A., Robert, F., Ethier, S., Schmeing, T. M., Dostie, J., & Pelletier, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109213 · Cited by 117
The molecular logic of Nanog-induced self-renewal in mouse embryonic stem cells
Heurtier, V., Owens, N. D. L., González, I., Mueller, F., Proux, C., Mornico, D., Clerc, P., Dubois, A., & Navarro, P. (2019) · Nature Communications · doi:10.1038/s41467-019-09041-z · Cited by 122
From Genomics to Gene Therapy: Induced Pluripotent Stem Cells Meet Genome Editing
Hotta, A., & Yamanaka, S. (2015) · Annual Review of Genetics · doi:10.1146/annurev-genet-112414-054926 · Cited by 124
Omichi, R., Shibata, S. B., Morton, C. C., & Smith, R. J. H. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz129 · Cited by 125
CRISPR/dCas9-Based Systems: Mechanisms and Applications in Plant Sciences
Karlson, C. K. S., Noor, S. N. M., Nolte, N., & Tan, B. C. (2021) · Plants · doi:10.3390/plants10102055 · Cited by 139
“[55] successfully reduced the off-target effect, while maintaining the on-target efficiency [55].”
BackgroundBottcher, R., Hollmann, M., Merk, K., Nitschko, V., Obermaier, C. D., Philippou‐Massier, J., Wieland, I., Gaul, U., & Förstemann, K. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku289 · Cited by 126
Lee, C. M., Cradick, T. J., Fine, E. J., & Bao, G. (2016) · Molecular Therapy · doi:10.1038/mt.2016.1 · Cited by 123
Self-citationStructural basis for genome wide recognition of 5-bp GC motifs by SMAD transcription factors
Martín-Malpartida, P., Palau, M. B., Kaczmarska, Z., Freier, R., Gomes, T., Aragón, E., Zou, Y., Wang, Q., Xi, Q., Ruiz, L., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02054-6 · Cited by 121
Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection
Huang, C., Lee, K.-C., & Doudna, J. A. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.05.006 · Cited by 119
LAMTOR/Ragulator is a negative regulator of Arl8b- and BORC-dependent late endosomal positioning
Filipek, P. A., de Araujo, M. E. G., Vogel, G. F., De Smet, C. H., Eberharter, D., Rebsamen, M., Rudashevskaya, E. L., Kremser, L., Yordanov, T., Tschaikner, P., et al. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201703061 · Cited by 119
First efficient CRISPR-Cas9-mediated genome editing in L eishmania parasites
Sollelis, L., Ghorbal, M., MacPherson, C. R., Martins, R. M., Kuk, N., Crobu, L., Bastien, P., Scherf, A., Lopez-Rubio, J.-J., & Sterkers, Y. (2015) · Cellular Microbiology · doi:10.1111/cmi.12456 · Cited by 120
Telomeric RNAs are essential to maintain telomeres
Montero, J. J., de Silanes, I. L., Graña‐Castro, O., & Blasco, M. A. (2016) · Nature Communications · doi:10.1038/ncomms12534 · Cited by 120
MARK4 inhibits Hippo signaling to promote proliferation and migration of breast cancer cells
Arash, E. H., Shiban, A., Song, S., & Attisano, L. (2017) · EMBO Reports · doi:10.15252/embr.201642455 · Cited by 119
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs
Shan, Y., Liang, Z., Qi, X., Zhang, T., Wang, B., Tian, S., Huang, W., Zhang, Y., Jiao, Y., Zhu, Y., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00668-4 · Cited by 124
Efficient generation of gene-modified pigs via injection of zygote with Cas9/sgRNA
Wang, Y., Du, Y., Shen, B., Zhou, X., Li, J., Liu, Y., Wang, J., Zhou, J., Hu, B., Kang, N., et al. (2015) · Scientific Reports · doi:10.1038/srep08256 · Cited by 119
Wiley, L. A., Burnight, E. R., DeLuca, A. P., Anfinson, K. R., Cranston, C. M., Kaalberg, E. E., Penticoff, J. A., Affatigato, L. M., Mullins, R. F., Stone, E. M., et al. (2016) · Scientific Reports · doi:10.1038/srep30742 · Cited by 120
Bajda, S., Dermauw, W., Panteleri, R., Sugimoto, N., Douris, V., Tirry, L., Osakabe, M., VONTAS, J. G., & Leeuwen, T. V. (2016) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2016.11.010 · Cited by 121
CRISPR/Cas9-mediated noncoding RNA editing in human cancers
Yang, J., Meng, X., Pan, J., Jiang, N., Zhou, C., Wu, Z., & Gong, Z. (2017) · RNA Biology · doi:10.1080/15476286.2017.1391443 · Cited by 122
Heavily and fully modified RNAs guide efficient SpyCas9-mediated genome editing
Mir, A., Alterman, J. F., Hassler, M. R., Debacker, A. J., Hudgens, E. D., Echeverria, D., Brodsky, M. H., Khvorova, A., Watts, J. K., & Sontheimer, E. J. (2018) · Nature Communications · doi:10.1038/s41467-018-05073-z · Cited by 112
Genome editing by natural and engineered CRISPR-associated nucleases
Wu, W. Y., Lebbink, J. H. G., Kanaar, R., Geijsen, N., & John van der, O. O. S. T. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0080-x · Cited by 119
Precision Control of CRISPR-Cas9 Using Small Molecules and Light
Gangopadhyay, S. A., Cox, K. J., Manna, D., Lim, D., Maji, B., Zhou, Q., & Choudhary, A. (2019) · Biochemistry · doi:10.1021/acs.biochem.8b01202 · Cited by 119
Bisht, D. S., Bhatia, V., & Bhattacharya, R. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.04.008 · Cited by 118
Evaluation and Reduction of CRISPR Off-Target Cleavage Events
Vakulskas, C. A., & Behlke, M. A. (2019) · Nucleic Acid Therapeutics · doi:10.1089/nat.2019.0790 · Cited by 130
Advanced CRISPR/Cas-based genome editing tools for microbial biofuels production: A review
Shanmugam, S., Ngo, H. H., & Wu, Y. (2019) · Renewable Energy · doi:10.1016/j.renene.2019.10.107 · Cited by 120
Giles, J. R., Manne, S., Freilich, E., Oldridge, D. A., Baxter, A. E., George, S. M., Chen, Z., Huang, H., Chilukuri, L., Carberry, M., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.02.004 · Cited by 121
Metadata
- Authors
- Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., Cradick, T. J., Marraffini, L. A., Bao, G., & Zhang, F.
- Affiliations
- Broad Institute (US)
- Georgia Institute of Technology (US)
- Koch Institute for Integrative Cancer Research At MIT (US)
- Rockefeller University (US)
- Corresponding author
- Zhang, Feng
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2013-07-21
- Volume
- 31
- Issue
- 9
- Pages
- 827-832
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC3969858
- OpenAlex
- W2036176224
- Cited by
- 4,741
- References
- 29
- Citations by year
- 2026: 242 · 2025: 300 · 2024: 304 · 2023: 331 · 2022: 372 · 2021: 424 · 2020: 416 · 2019: 422 · 2018: 463 · 2017: 438 · 2016: 402 · 2015: 297 · 2014: 269 · 2013: 53
- FWCI
- 152.56
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion)
- PMC
- Funders
- National Science Foundation
- Howard Hughes Medical Institute
- Damon Runyon Cancer Research Foundation
- McKnight Foundation
- Life Sciences Research Foundation
- National Institutes of Health (R01‐grant, GM34277)
- Harvard Stem Cell Institute
- National Institute of Mental Health (DP1MH100706)
- National Eye Institute (PN2EY018244)
- National Cancer Institute (R01CA133404)
- National Institute of General Medical Sciences (R01GM034277, R01 GM34277, T32GM007753)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK097768)
- National Center for Chronic Disease Prevention and Health Promotion (DP1‑MH100706)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- SpCas9, single guide RNA, genome editing, off-target effects, mismatch tolerance, DNA methylation, indel mutations, guide RNA design, target site selection, HEK293T cells, web-based design tool
- MeSH terms
- Bacterial Proteins, Base Sequence, Deoxyribonucleases, DNA, Genetic Engineering, Molecular Sequence Data, Streptococcus pyogenes, Transcription Factors, Base Pair Mismatch, RNA, Small Untranslated
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
